Mubadala capital co-leads $200mn funding for Tenvie Therapeutics

GHADA.ISMAIL
Jan 12, 2025

Dubai – Sharikat Mubasher: Tenvie Therapeutics launched today with a mission to transform neurological disease treatment.

The company, backed by $200 million in funding, has drawn significant support from Mubadala Capital, along with ARCH Venture Partners and F-Prime Capital, according to a recent press release.

Combining assets acquired from Denali Therapeutics Inc. with an expert R&D team, Tenvie aims to develop groundbreaking small molecule therapies.

Tony Estrada, Ph.D., President and Chief Scientific Officer of Tenvie commented: “Tenvie was founded to fundamentally alter the treatment paradigm for neurological diseases and profoundly impact the lives of patients, their families, and caregivers”. The company focuses on resolving inflammation, rescuing metabolic dysfunction, and restoring lysosomal function, with advanced programs like an NLRP3 inhibitor and an allosteric SARM1 inhibitor already in the IND-enabling stage.

Alaa Halawa, Mubadala Capital’s Head of Healthcare and a Tenvie Board Director, highlighted the importance of the company’s mission, saying: “Tenvie’s approach demonstrates a commitment to addressing unmet needs in neurology”. Mubadala Capital’s investment underscores its strategy to back innovative ventures addressing critical healthcare challenges.

Tenvie’s leadership team includes accomplished figures in CNS drug development and business operations, positioning the company to lead advancements in neurology. With Mubadala Capital’s support, Tenvie is set to make significant strides in delivering next-generation therapies for patients worldwide.


Share

Related News

Vast Menu collects SAR 5 mn in pre-seed round
News
Calendar Icon
February 13, 2025
Vast Menu collects SAR 5 mn in pre-seed round
readmore
PIESHIP raises $2.1mn to scale last-mile delivery across Saudi Arabia
News
Calendar Icon
February 13, 2025
PIESHIP raises $2.1mn to scale last-mile delivery across Saudi Arabia
readmore
Ebra closes $2mn seed round at LEAP 2025
News
Calendar Icon
February 13, 2025
Ebra closes $2mn seed round at LEAP 2025
readmore
Tabby raises $160mn series E round at $3.3bn valuation
News
Calendar Icon
February 13, 2025
Tabby raises $160mn series E round at $3.3bn valuation
readmore
Saudi Arabia backs Groq with $1.5bn to strengthen AI infrastructure
News
Calendar Icon
February 13, 2025
Saudi Arabia backs Groq with $1.5bn to strengthen AI infrastructure
readmore
RasMal raises SAR 18 mn pre-series A round at LEAP 2025
News
Calendar Icon
February 12, 2025
RasMal raises SAR 18 mn pre-series A round at LEAP 2025
readmore
LAHINT secures SAR 4mn pre-seed funding at LEAP 25
News
Calendar Icon
February 11, 2025
LAHINT secures SAR 4mn pre-seed funding at LEAP 25
readmore
WideBot secures $3mn funding to develop Arabic-centric AI model ‘AQL’
News
Calendar Icon
February 11, 2025
WideBot secures $3mn funding to develop Arabic-centric AI model ‘AQL’
readmore
Mohami closes SAR 1 mn pre-seed round, raises valuation to SAR 15 mn
News
Calendar Icon
February 9, 2025
Mohami closes SAR 1 mn pre-seed round, raises valuation to SAR 15 mn
readmore
String secures SAR 2 mn in pre-seed funding
News
Calendar Icon
February 9, 2025
String secures SAR 2 mn in pre-seed funding
readmore